Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases

被引:348
作者
Trushina, E.
McMurray, C. T.
机构
[1] Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Mol Neurosci Program, Rochester, MN 55905 USA
关键词
neurodegeneration; mitochondria; oxidative damage; Huntington's disease; Friedreich ataxia; xeroderma pigmentosum;
D O I
10.1016/j.neuroscience.2006.10.056
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In recent years, it has become increasingly clear that mitochondrial dysfunction and oxidative damage are major contributors to neuronal loss. Free radicals, typically generated from mitochondrial respiration, cause oxidative damage of nucleic acids, lipids, carbohydrates and proteins. Despite enormous amount of effort, however, the mechanism by which oxidative damage causes neuronal death is not well understood. Emerging data from a number of neurodegenerative diseases suggest that there may be common features of toxicity that are related to oxidative damage. In this review, while focusing on Huntington's disease (HD), we discuss similarities among HD, Friedreich ataxia and xeroderma pigmentosum, which provide insight into shared mechanisms of neuronal death. (C) 2006 Published by Elsevier Ltd on behalf of IBRO.
引用
收藏
页码:1233 / 1248
页数:16
相关论文
共 175 条
[1]   Iron-dependent self assembly of recombinant yeast frataxin: Implications for Friedreich ataxia [J].
Adamec, J ;
Rusnak, F ;
Owen, WG ;
Naylor, S ;
Benson, LM ;
Gacy, AM ;
Isaya, G .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (03) :549-562
[2]   Chelatases: distort to select? [J].
Al-Karadaghi, S ;
Franco, R ;
Hansson, M ;
Shelnutt, JA ;
Isaya, G ;
Ferreira, GC .
TRENDS IN BIOCHEMICAL SCIENCES, 2006, 31 (03) :135-142
[3]   Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease [J].
Andreassen, OA ;
Dedeoglu, A ;
Ferrante, RJ ;
Jenkins, BG ;
Ferrante, KL ;
Thomas, M ;
Friedlich, A ;
Browne, SE ;
Schilling, G ;
Borchelt, DR ;
Hersch, SM ;
Ross, CA ;
Beal, MF .
NEUROBIOLOGY OF DISEASE, 2001, 8 (03) :479-491
[4]   Complex I defect in muscle from patients with Huntington's disease [J].
Arenas, J ;
Campos, Y ;
Ribacoba, R ;
Martín, MA ;
Rubio, JC ;
Ablanedo, P ;
Cabello, A .
ANNALS OF NEUROLOGY, 1998, 43 (03) :397-400
[5]   p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease [J].
Bae, BI ;
Xu, H ;
Igarashi, S ;
Fujimuro, M ;
Agrawal, N ;
Taya, Y ;
Hayward, SD ;
Moran, TH ;
Montell, C ;
Ross, CA ;
Snyder, SH ;
Sawa, A .
NEURON, 2005, 47 (01) :29-41
[6]  
BEAL MF, 1991, J NEUROSCI, V11, P1649
[7]   DOES IMPAIRMENT OF ENERGY-METABOLISM RESULT IN EXCITOTOXIC NEURONAL DEATH IN NEURODEGENERATIVE ILLNESSES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1992, 31 (02) :119-130
[8]   Mitochondria take center stage in aging and neurodegeneration [J].
Beal, MF .
ANNALS OF NEUROLOGY, 2005, 58 (04) :495-505
[9]   Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated Huntingtin [J].
Benchoua, A ;
Trioulier, Y ;
Zala, D ;
Gaillard, MC ;
Lefort, N ;
Dufour, N ;
Saudou, F ;
Elalouf, JM ;
Hirsch, E ;
Hantraye, P ;
Déglon, N ;
Brouillet, E .
MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (04) :1652-1663
[10]   Deranged neuronal calcium signaling and Huntington disease [J].
Bezprozvanny, I ;
Hayden, MR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 322 (04) :1310-1317